HMA - Heads of Medicines Agencies
  • RSS
  • Sitemap
  • Contact
  • About HMA
  • Human Medicines
  • Veterinary Medicines
  • You are here:
  • Home
  • >About HMA
  • Vision and mission
  • Structure
  • Working Groups
  • National Contacts
  • COVID-19
  • Combination products
  • Transparency
  • Meetings
  • Medicines Approval system
  • Publications and reports
  • Recently Published
  • Newsletters

 

Recently pusblished or updated pages

March 2026

10 March 2026

  • NEW: Pharmaceuticals in the Environment (PiE)
  • NEW: Pharmaceuticals in the Environment (PiE)

December 2025

17 December 2025

  • NEW: HMA HRM and L&D Working Group
  • NEW: HMA HRM and L&D working group
  • UPDATE: HMA-EMA Network Data Steering Group (NDSG)

October 2025

02 October 2025

  • NEW: HMA-EMA Network Data Steering Group (NDSG)
  • NEW: HMA/EMA Joint Network Data Steering Group (NDSG)
  • UPDATE: ARCHIVE OF WORKING GROUPS
  • UPDATE: HMA Core Group for Medical Devices (CGMD)
  • UPDATE: HMA Core Group for Medical Devices (CGMD)
  • UPDATE: Homeopathic Medicinal Products Working Group (HMPWG)
  • UPDATE: Clinical Trials Coordination Group (CTCG)
  • UPDATE: HMA Working Group of Quality Managers (WGQM)
  • UPDATE: Working Group of Enforcement Officers (WGEO)
  • UPDATE: Working Group of Enforcement Officers (WGEO)
  • UPDATE: Working Group of Communication Professionals (WGCP)
  • UPDATE: Working Group of Communication Professionals (WGCP)
  • UPDATE: HMA Substances Validation Group (SVG)
  • UPDATE: HMA Substances Validation Group (SVG)

For the United Kingdom, as of 1 January 2021, European Union law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland / NI.

  • Useful Links
  • Privacy Policy
  • Credits & Disclaimer
  • Contact
© Heads of Medicines Agencies - https://www.hma.eu/about-hma/new-modified-pages.html